Latest Clinical trial Stories

ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials

2013-06-10 16:25:54

TAMPA, Fla., June 10, 2013 /PRNewswire-USNewswire/ -- ISPE, the International Society for Pharmaceutical Engineering, announced today it is currently conducting a global survey on patient experiences with clinical trial materials. The survey is designed to obtain feedback on areas such as the suitability of clinical trial packaging, label information and design, interacting with clinical trial technologies, and transportation and storage. With a target of 2000 or more patients from...

MiMedx Announces Publication Of The Results From A Randomized Controlled Trial Of Its Advanced Wound Care Allograft, EpiFix(R)

2013-06-10 12:26:13

MARIETTA, Ga., June 10, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that a randomized controlled trial (RCT) for the Company's EpiFix(R) wound care allograft has been published in the International Wound Journal. Parker H. "Pete" Petit, Chairman and CEO, said, "The results of this clinical trial were...

AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management

2013-06-10 08:30:32

Innovative integrated technology approach aims to link partners seamlessly to improve efficiency and management of clinical studies CONSHOHOCKEN, Pa., June 10, 2013 /PRNewswire/ -- ePharmaSolutions, a leading clinical services and eClinical solutions provider, has signed a deal with AstraZeneca Neuroscience Innovative Medicines (AZ NS iMed), to provide IT solutions that will enable the iMed to share and manage complex data on a common portal with clinical trial investigators and...

Echo Therapeutics Submits Pre-Submission Package to FDA for Symphony® CGM System

2013-06-10 08:29:48

PHILADELPHIA, June 10, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it has submitted a pre-submission package to the U.S. Food and Drug Administration (FDA) for the Symphony CGM System for use in the hospital critical care environment. In conjunction with the pre-submission package, the Company has requested a meeting with...

Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel

2013-06-10 08:29:43

Oramed to Present on Tuesday, June 11, 2013, at 3:10 p.m. (IDT) JERUSALEM, June 10, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a clinical-stage developer of oral delivery systems, announced today that it has been invited to present at the 12th National Life Science & Technology Week IATI-BioMed Conference taking place from June 10-12, 2013, in Tel Aviv, Israel. Josh Hexter, Oramed's Chief Operating Officer and Vice President of Business Development,...

Added Benefit Of Ingenol Mebutate Is Not Proven

2013-06-06 11:42:47

Manufacturer's dossier did not contain any relevant data for the comparison with diclofenac/hyaluronic acid gel The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new...

Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM System

2013-06-05 08:28:31

PHILADELPHIA, June 5, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe. The Company expects to enroll patients over the coming weeks and announce the results of the study in the third...

CROnos Clinical Consulting Appoints Pamela Keenan, Vice President, Scientific Affairs

2013-06-05 08:28:06

20-year veteran brings scientific expertise in Alzheimer's Disease HAMILTON, N.J., June 5, 2013 /PRNewswire/ -- CROnos Clinical Consulting, a global neuroscience focused clinical data quality control organization (QCO) with proven processes for delivering results, announced today that Dr. Pamela Keenan has joined the Company as Vice President, Scientific Affairs. Dr. Keenan joins CROnos from Johnson & Johnson, where she served most recently in Global Medical Affairs for Janssen...

California CRO, WCCT Global Announces Success in Recruiting 300 Subjects in 3 Weeks for a Large Clinical Trial

2013-06-04 23:25:36

WCCT Global, a California CRO, was able to recruit 300 subjects in a 3 week period for large phase I clinical trial. Costa Mesa, California (PRWEB) June 04, 2013 WCCT Global, a contract research organization headquartered in Southern California announced today the successful enrollment of 300 subjects at one site for a phase I study. For this clinical trial, the recruitment had to be done extremely quickly due to the strict timelines given to screen and randomize the subjects. All...

HealthCarePoint Pledges More Than $10 Million in Software and Technology Services to Help Support ACRES Global Network for Clinical Research

2013-06-04 23:16:39

Connecting HealthCare and Clinical Research Austin-Cedar Park, Texas (PRWEB) June 04, 2013 HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking technology corporation, today formally announced that it is pledging more than $10 million in technologies and infrastructure services to ACRES, the Alliance for Clinical Research Excellence and Safety, a Cambridge-based non-profit organization established to develop a global system for improving quality, safety, ethics...